The SA Journal Diabetes & Vascular Disease Volume 18 No 1 (July 2021)

1 / 18

Featured in this issue:
Volume 18 Number 1
BISOPROLOL:
• HIGHLY SELECTIVE ß-BLOCKER
• 24 HOUR BP REDUCTION
• DOSING FLEXIBILITY
BILOCOR 5, 10. Each tablet contains 5, 10 mg bisoprolol fumarate respectively. S3 A38/5.2/0053, 0051. NAM NS2 06/5.2/0061, 0062.
For full prescribing information, refer to the professional information approved by SAHPRA, 23 July 2010. BILOCOR CO 2,5/6,25, 5/6,25,
10/6,25. Each tablet contains 2,5, 5, 10 mg bisoprolol fumarate respectively and 6,25 mg hydrochlorothiazide. S3 A44/7.1.3/1010, 1011,
1012. NAM NS2 13/7.1.3/0260, 0261, 0262. For full prescribing information, refer to the professional information approved by SAHPRA,
6 May 2019. BRI731/05/2021.
CUSTOMER CARE LINE 0860 PHARMA (742 762) / +27 21 707 7000
July 2021
SAJDVD
The South African Journal of Diabetes & Vascular Disease
The electronic version of
the journal is available at
• Prevalence of
gestational diabetes in
urban Blantyre, Malawi
• Severe bradycardia
caused by diabetic
ketoacidosis
Reviews Research Articles Patient Leaflets Drug Trends News